Tamoxifen Mechanism of Action Review Hub

Tamoxifen is a selective estrogen receptor modulator targeting ERalpha and ERbeta, widely investigated in breast cancer therapeutics, endocrine resistance mechanisms, apoptosis, autophagy, and Cre-ERT2 inducible genetic recombination systems. This hub brings together literature-reported mechanisms across diverse biological pathways and research areas, helping you explore its molecular actions.

Breast Cancer Therapeutics

  1. Inhibits Cell Proliferation Across Extensive
  2. Efficacy Evaluation in Patient-Derived Organoids
  3. Retards Tumor Growth Kinetics
  4. Suppresses Ki-67 Nuclear Labeling Indices
  5. Displays Superior Anti-Tumor Efficacy
  6. Inhibits Anchorage-Independent Colony Formation
  7. Benchmarked Against Fulvestrant in Estrogen
  8. Alters Metabolomic Profiles in Luminal
  9. Treatment Suppresses Spontaneous Metastatic Dissemination
  10. Suppresses Mammosphere Formation Frequency
  11. Pharmacodynamics Profiled via Longitudinal Bioluminescent
  12. Efficacy Correlates Inversely with Baseline
  13. Suppresses Extracellular Matrix Invasion
  14. Downregulates HER3 Expression and Signaling

Tamoxifen in Estrogen Receptor Signaling

  1. Displaces 17beta-Estradiol to Antagonize Estrogen
  2. Modulates ERbeta Heterodimerization Dynamics
  3. Induces Conformational Inactivation of ERalpha
  4. Inhibits Estrogen-Driven c-Myc and Cyclin
  5. Alters Coactivator SRC-1 Recruitment Kinetics
  6. Differentiates Agonist and Antagonist Conformations
  7. Regulates FoxA1 Pioneer Factor Colocalization
  8. Restricts Endogenous TFF1/pS2 Promoter Activation
  9. Induces Specific Estrogen Receptor Alpha
  10. Modulates Direct Protein-Protein Interactions Between
  11. Downregulates GREB1 Transcription to Impair
  12. Suppresses Ligand-Independent Estrogen Receptor Alpha
  13. Suppresses Nuclear Coactivator Complex Assembly

Endocrine Resistance

  1. Resistance in Breast Cancer Driven
  2. Fails to Repress Growth Factor
  3. Resistance Drives Hyperactivation of PI3K/AKT/mTOR
  4. in Resistant Mammary Cultures Displays
  5. Exposure in Long-Term Refractory Models
  6. Epigenetic Silencing of ESR1 via
  7. SOX2 Driven Metastatic Stemness
  8. Desensitization Mediated by EGFR
  9. Efficacy Restoration via CDK4/6 Inhibition
  10. Resistance Upregulates ABC Transporter Family
  11. Refractory Mammary Tumors Display Extensive
  12. Resistance Selection Generates Cross-Resistance Profiles
  13. Resistance Reversal Using Epigenetic HDAC

Cre-ERT2 Recombination Systems

  1. Administration Regimens Determine Spatiotemporal Cre-ERT2
  2. 4-Hydroxytamoxifen Metabolite Selectivity
  3. Fatal Neonatal Hematological Hypoplasia
  4. Induces Neural Cellular Stress
  5. Enriched Diet Induces Cardiomyopathy and
  6. Administration Induces Off-Target Behavioral Alterations
  7. Exhibits Sex-Divergent Off-Target Effects
  8. Local Delivery Protocols Maximize Site-Directed
  9. Optimizing Central Nervous System Cre-ERT2
  10. Regimen Kinetics Modulate Refractory Endothelial
  11. Variable Organ Rosa26 Cleavage Efficiencies
  12. Off-Target Immunomodulatory Signals Confound Cre-ERT2

Tamoxifen-Mediated Apoptosis

  1. Mediated Apoptosis Follows Cytochrome c
  2. Downregulates Bcl-2 and Mcl-1 Expression
  3. Activates Cleaved PARP and Caspase-7
  4. Directs Bax and Bak Translocation
  5. Triggers Extrinsic Fas/FasL Upregulation Leading
  6. Mediated Apoptosis Requires Intracellular Calcium
  7. Overcomes Apoptosis Resistance via Survivin
  8. Induces DNA Fragmentation and Terminal
  9. Mediated Apoptosis Correlates with Ceramide
  10. Stimulates Smac/DIABLO Release from Mitochondria
  11. Elicits Differential Apoptotic Kinetics
  12. Triggers Bim Induction and Phosphorylation

Tamoxifen-Induced Autophagy

  1. Autophagy Acts as a Protective
  2. Increases LC3B-II Lipidation and Puncta
  3. Suppresses mTORC1 Signaling Through AMPK
  4. Regulates p62/SQSTM1 Degradation Dynamics
  5. Autophagy Sensitizes Mammary Carcinoma Cells
  6. Promotes Beclin-1 Dissociation from Bcl-2
  7. Autophagic Cell Death Preponderates
  8. Inhibits Lysosomal Acidification via Cationic
  9. Triggers ULK1 Dephosphorylation at Ser757
  10. Mediated Autophagic Clearance of Damaged
  11. Hydroxychloroquine Reversal in Luminal Xenografts

Immune Microenvironment Modulation

  1. Macrophage CCL2 Axis Reprogramming
  2. Siglec Myeloid Checkpoint Regulation
  3. Prostate PIP5K1alpha Signaling Suppression
  4. Endothelial Angiogenesis Pathway Reprogramming
  5. Mitochondrial Complex I AMPK Activation
  6. Neutrophil Cytotoxicity via Ceramide Accumulation
  7. Regulatory T Cell Phenotypic Modulation
  8. CD8+ Lymphocyte Infiltration Enhancement
  9. Gut Microbiota and Cytokine Cascades
  10. Caspase-1 Dependent Cytokine Maturation

Oxidative Stress

  1. Driven ROS Accumulation Activates Nrf2
  2. Metabolite 3,4-diOH-TAM Accelerates Catechol-Mediated Redox
  3. Induces Radioresistance in Mammary Carcinoma
  4. Toremifene in Induction
  5. Hepatic Lipid Peroxidation and Mitochondrial
  6. Impairs Glutathione Reductase and Elevates
  7. Cytotoxicity Modulated by Exogenous Antioxidants
  8. Elicits Cytotoxic Reactive Oxygen Species
  9. DNA Strand Scission Quantified
  10. Associated Vascular Oxidative Damage and

Cell Cycle Arrest

  1. G0/G1 Cell Cycle Arrest
  2. Downregulates Cyclin D1 Expression Preceding
  3. Stabilizes p21 Cip1 and p27
  4. Suppresses Retinoblastoma Protein Phosphorylation
  5. Inhibits DNA Replication Synthesis Evaluated
  6. Mediates Cyclin E Downregulation
  7. Triggered Cytostatic Reversibility Assessment Following
  8. Induces Cellular Senescence Markers Upregulating
  9. Modulates Skp2 Ubiquitin Ligase Expression
  10. Represses CDC25A Phosphatase Transcription Leading

Epigenetic Reprogramming

  1. Selectively Induces Alterations in DNA
  2. Resistance Reprograms Polycomb Repressive Complex
  3. Histone Deacetylase Inhibitor Synergy
  4. Macrophage Extracellular Vesicle Signaling
  5. Inducible Cre-ERT2 Murine Systems
  6. Bioactive Stilbene Derivative Comparisons
  7. Neuroprotective REST Acetylation Signatures
  8. HOXA5 Hyperactivation Resistance Cascades
  9. Genome-Wide Polymerase Pausing Regulation

Neuroprotection

  1. Subarachnoid Hemorrhage Inflammatory Suppression
  2. Spinal Contusion Locomotor Recovery
  3. Pathologic TDP-43 Autophagic Clearance
  4. Hypoxic-Ischemic Cerebral Infarction Reduction
  5. Hippocampal Dendritic Spine Plasticity
  6. Nigrostriatal Dopaminergic Terminal Rescue
  7. Traumatic CNS Microglial Attenuation
  8. Comparative Amyloid Neurotoxicity Mitigation
  9. Post-Encephalitic Progenitor Cell Modulation

Non-Mammary Malignancies

  1. Temozolomide Resistance Reversal in Glioblastoma
  2. Acid Ceramidase Amitotic Division Suppression
  3. Estrogen Receptor Beta Lymphoma Apoptosis
  4. Platelet Mediated Peritoneal Metastasis Repression
  5. Gefitinib Synergy in Lung Carcinoma
  6. Progestin Combinations in Endometrial Carcinoma
  7. Thyroid Carcinoma Invasive Migration Blockade
  8. Sulindac Synergy in Desmoid Fibromatosis
  9. Solid Tumor Non-Receptor Molecular Targets

Drug Combination Synergy

  1. Dexamethasone Synergy in Resistant Cells
  2. Kinase and Protease Inhibitor Screening
  3. Lovastatin Dual-Agent Dilution Assays
  4. Dinaciclib Mediated Proliferative Suppression
  5. Cholesterol Depletion Mediated Sensitization
  6. Resveratrol Nanocarrier Co-Delivery Systems
  7. Retinoid Synergism Median-Effect Modeling
  8. ESR1 Mutation Synergy Matrix Profiling
  9. Analgesic Driven Cytochrome P450 Alterations

ER Stress

  1. Triggered ER Stress Activates BiP/eIF2alpha/CHOP
  2. Modulates IRE1alpha Signaling via HBXIP
  3. Regulates PPIB Secretion from ER-Positive
  4. Persin Enhances Cytotoxicity
  5. Drives Phosphorylation of eIF2alpha within
  6. Selectively Induces IRE1alpha/XBP1 Splicing
  7. Alters GPER Subcellular Relocalization
  8. Triggered Endoplasmic Reticulum Stress Antagonizes
  9. Perturbs Chaperone BiP Expression

Mitochondrial Dysfunction

  1. Impairs Mitochondrial Respiration and Depolarizes
  2. Derivative MitoTam Selectively Eliminates Senescent
  3. Modulates Cyclophilin-D and Mitochondrial Calcium
  4. Attenuates Ovarian Chemo-Toxicity by Upregulating
  5. Resistance in Breast Cancer Driven
  6. Potentiates Mitochondrial Superoxide Dismutase
  7. Induces Inner Mitochondrial Membrane Depolarization
  8. Derived Metallodrugs Induce Rapid Cytochrome
  9. Perturbs Endolysosomal Iron Homeostasis Causing